文献速递神经核医学

氟贝他吡PET显像定量分析作为视觉判读辅助的价值

Quantitation of PET signal as an adjunct to visual interpretation of florbetapir imaging.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2017-01-07

本研究训练80名医师对氟贝他吡PET淀粉样蛋白显像进行定量分析辅助视觉判读,对96例扫描(46例尸检验证、50例寻求诊断)进行判读。定量辅助判读使准确率从90.1%提升至93.1%(p<0.0001),且未降低高于平均水平判读者的准确率,在临床相关病例中VisQ组较VisVis组显著改善(变化5.4% vs -1.1%,p<0.0001)。

要点

  • 定量辅助视觉判读使尸检验证扫描准确率从90.1%提升至93.1%(p<0.0001)。
  • 定量信息未降低高于平均水平判读者的判读准确率。
  • 寻求诊断病例中VisQ组较VisVis组显著改善(变化5.4% vs -1.1%,p<0.0001)。

核心结论

  • 使用商用软件包获得的定量信息辅助氟贝他吡PET淀粉样蛋白图像的视觉判读,未降低已具有高于平均水平视觉判读准确率的判读者的准确率,并可能改善部分判读者在临床相关病例中的准确率和信心。

研究设计与样本

  • 共80名医师判读者接受氟贝他吡PET图像定量分析及定量辅助视觉判读原则的培训。
  • 第1天判读者完成96例扫描的视觉判读(46例尸检验证,50例来自寻求诊断的患者)。
  • 第2天69名判读者使用三种商用软件包之一,以定量辅助(VisQ方法)重新判读96例扫描。
  • 11名判读者亚组在第2天仅基于视觉判读(VisVis对照)重新判读所有扫描。
  • 尸检验证扫描以神经病理学家的改良CERAD斑块评分作为判读准确性的真实标准。

主要发现

  • 第1天视觉判读准确率在尸检验证扫描中为90%,在寻求诊断患者的扫描中为87.3%。
  • 从视觉判读到VisQ判读,准确率从90.1%提升至93.1%(p<0.0001)。
  • 获取定量信息未降低高于平均水平判读者(第1天>90%)的判读准确率。
  • 尸检验证扫描的判读准确率从第一次视觉判读到第二次视觉判读(VisVis组)也有所提高。
  • 寻求诊断患者的扫描中,与参考标准(最佳判读者)的一致性在第二次视觉判读时未改善,VisQ组较VisVis组显著改善(变化5.4% vs -1.1%,p<0.0001)。

临床怎么用

  • 作者认为,使用商用软件包获得的定量信息辅助氟贝他吡PET淀粉样蛋白图像的视觉判读,可能改善部分判读者在临床相关病例中的准确率和信心。

局限性

  • 寻求诊断患者的扫描因无尸检真实标准,以在尸检验证扫描判读中准确率最好的3名判读者的多数VisQ判读作为参考标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study examined the feasibility of using quantitation to augment interpretation of florbetapir PET amyloid imaging. METHODS: A total of 80 physician readers were trained on quantitation of florbetapir PET images and the principles for using quantitation to augment a visual read. On day 1, the readers completed a visual read of 96 scans (46 autopsy-verified and 50 from patients seeking a diagnosis). On day 2, 69 of the readers reinterpreted the 96 scans augmenting their interpretation with quantitation (VisQ method) using one of three commercial software packages. A subset of 11 readers reinterpreted all scans on day 2 based on a visual read only (VisVis control). For the autopsy-verified scans, the neuropathologist's modified CERAD plaque score was used as the truth standard for interpretation accuracy. Because an autopsy truth standard was not available for scans from patients seeking a diagnosis, the majority VisQ interpretation of the three readers with the best accuracy in interpreting autopsy-verified scans was used as the reference standard. RESULTS: Day 1 visual read accuracy was high for both the autopsy-verified scans (90%) and the scans from patients seeking a diagnosis (87.3%). Accuracy improved from the visual read to the VisQ read (from 90.1% to 93.1%, p < 0.0001). Importantly, access to quantitative information did not decrease interpretation accuracy of the above-average readers (>90% on day 1). Accuracy in interpreting the autopsy-verified scans also increased from the first to the second visual read (VisVis group). However, agreement with the reference standard (best readers) for scans from patients seeking a diagnosis did not improve with a second visual read, and in this cohort the VisQ group was significantly improved relative to the VisVis group (change 5.4% vs. -1.1%, p < 0.0001). CONCLUSION: These results indicate that augmentation of visual interpretation of florbetapir PET amyloid images with quantitative information obtained using commercially available software packages did not reduce the accuracy of readers who were already performing with above average accuracy on the visual read and may improve the accuracy and confidence of some readers in clinically relevant cases.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Pontecorvo MJ, Arora AK, Devine M, et al. Quantitation of PET signal as an adjunct to visual interpretation of florbetapir imaging. Eur J Nucl Med Mol Imaging. 2017. PMID: 28064343. doi:10.1007/s00259-016-3601-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。